Continued Exploration of Bevacizumab in Breast Cancer.
Mehta
Rita S
RS
Division of Hematology/Oncology, Department of Medicine, and Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, CA, USA.
Su
Min-Ying
MY
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal